Clinical trial

EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular…

NCT00187889 · University of Florida, Other · Completed

Key facts

NCT number NCT00187889
Title EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
Official title A Double-Blind, Multicenter, Placebo Controlled Study of Aldosterone Blockade (Eplerenone) in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia in the Absence of Significant Epicardial Coronary Artery Disease
Lead sponsor University of Florida, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH Pfizer Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Ischemic Heart Disease
Intervention type Drug
Interventions Eplerenone, Placebo or sugar pill
Enrollment 70
Start date Aug 1, 2004
Primary completion Feb 1, 2009
Completion Dec 1, 2011
First posted Sep 16, 2005
Last update posted Oct 14, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies